CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
Revenue	$ 7,000	$ 5,000
Operating expenses:
Research and development	40,166	33,046
General and administrative	13,770	10,161
Total operating expenses	53,936	43,207
Loss from operations	(46,936)	(38,207)
Other income:
Grant income	2,300	5,337
Interest income	1,463	390
Total other income	3,763	5,727
Loss before income taxes	(43,173)	(32,480)
Provision for income taxes	677	472
Net loss	(43,850)	(32,952)
Dividends declared		(9,142)
Net Loss per Share
Net loss attributable to common stockholders—basic and diluted	$ (43,850)	$ (42,094)
Net loss per share—basic and diluted (in dollar per share)	$ (3.33)	$ (12.31)
Weighted average common stock outstanding—basic and diluted (in shares)	13,160,357	3,419,720
Other comprehensive loss
Net loss	$ (43,850)	$ (32,952)
Net unrealized gain (loss) on investments held	9	(9)
Comprehensive loss	$ (43,841)	$ (32,961)